These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9501184)

  • 61. Novel synthesis of the glycosidase inhibitor deoxymannojirimycin and of a synthetic precursor D-lyxo-hexos-5-ulose.
    O'Brien JL; Tosin M; Murphy PV
    Org Lett; 2001 Oct; 3(21):3353-6. PubMed ID: 11594832
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors.
    Taylor RH; Barker HM; Bowey EA; Canfield JE
    Gut; 1986 Dec; 27(12):1471-8. PubMed ID: 3804023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanistic insights into glycosidase chemistry.
    Vocadlo DJ; Davies GJ
    Curr Opin Chem Biol; 2008 Oct; 12(5):539-55. PubMed ID: 18558099
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Purification of an isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase and its substrates from Dalbergia nigrescens Kurz.
    Chuankhayan P; Hua Y; Svasti J; Sakdarat S; Sullivan PA; Ketudat Cairns JR
    Phytochemistry; 2005 Aug; 66(16):1880-9. PubMed ID: 16098548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors.
    Dong W; Jespersen T; Bols M; Skrydstrup T; Sierks MR
    Biochemistry; 1996 Feb; 35(8):2788-95. PubMed ID: 8611585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glycosidase inhibition: assessing mimicry of the transition state.
    Gloster TM; Davies GJ
    Org Biomol Chem; 2010 Jan; 8(2):305-20. PubMed ID: 20066263
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de-O-sulfonated derivative.
    Mohan S; Sim L; Rose DR; Pinto BM
    Bioorg Med Chem; 2010 Nov; 18(22):7794-8. PubMed ID: 20970346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nucleophilic opening of epoxyazepanes: expanding the family of polyhydroxyazepane-based glycosidase inhibitors.
    Li H; Schütz C; Favre S; Zhang Y; Vogel P; Sinaÿ P; Blériot Y
    Org Biomol Chem; 2006 May; 4(9):1653-62. PubMed ID: 16633556
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protodioscin-glycosidase-1 hydrolyzing 26-O-β-D-glucoside and 3-O-(1 → 4)-α-L-rhamnoside of steroidal saponins from Aspergillus oryzae.
    Liu T; Yu H; Liu C; Wang Y; Tang M; Yuan X; Luo N; Wang Q; Xu X; Jin F
    Appl Microbiol Biotechnol; 2013 Dec; 97(23):10035-43. PubMed ID: 23467827
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis of alkylated deoxynojirimycin and 1,5-dideoxy-1,5-iminoxylitol analogues: polar side-chain modification, sulfonium and selenonium heteroatom variants, conformational analysis, and evaluation as glycosidase inhibitors.
    Szczepina MG; Johnston BD; Yuan Y; Svensson B; Pinto BM
    J Am Chem Soc; 2004 Oct; 126(39):12458-69. PubMed ID: 15453780
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A general strategy for the practical synthesis of nojirimycin C-glycosides and analogues. Extension to the first reported example of an iminosugar 1-phosphonate.
    Godin G; Compain P; Masson G; Martin OR
    J Org Chem; 2002 Oct; 67(20):6960-70. PubMed ID: 12353989
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycosidase inhibitors as conformational transition state analogues.
    Greig IR; Williams IH
    Chem Commun (Camb); 2007 Sep; (36):3747-9. PubMed ID: 17851615
    [TBL] [Abstract][Full Text] [Related]  

  • 75. General approach to glycosidase inhibitors. Enantioselective synthesis of deoxymannojirimycin and swainsonine.
    Martín R; Murruzzu C; Pericàs MA; Riera A
    J Org Chem; 2005 Mar; 70(6):2325-8. PubMed ID: 15760222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unusual enzymatic glycoside cleavage mechanisms.
    Jongkees SA; Withers SG
    Acc Chem Res; 2014 Jan; 47(1):226-35. PubMed ID: 23957528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of Side Chain Conformation on the Activity of Glycosidase Inhibitors.
    Tseng PS; Ande C; Moremen KW; Crich D
    Angew Chem Int Ed Engl; 2023 Feb; 62(8):e202217809. PubMed ID: 36573850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.